The disease care model is not sustainable.
~90% of healthcare $ are spent on chronic diseases of aging. That number is increasing. When does it break?
We should prioritize biological aging and develop therapies that keep people healthy instead of keeping them sick
Extremely grateful for the opportunity to attend my first OARSI - Osteoarthritis Research Society International meeting! I have learned a lot about this complex disease that is Osteoarthritis and met great people. Excited indeed for the potential impact t…https://t.co/zZANBnYmPT
I don’t usually post personal news but Clinicians have told us to pull every lever.
Our daughter has with #dipg Brain cancer. There is no cure and typically 9m life expectancy.
If anyone knows of trials then please get in contact! #braincancer#childrenscancer@CR_UK
A part-time or full-time position as In Vivo Technician is open at Dorian Therapeutics.
Join our team and effort to treat age-related diseases and bring Dorian's senoblockers to the clinic!
#hiring#team#startup#aging#longevity https://t.co/J2bN87EEnA
@TFTP_France is a non-profit company raising €1 billion to create 100 companies that will fight against global warming 🔥 🌏. To read more about the project or become a partner, check out https://t.co/60Zi7HWBLC
We are already thousands, let’s make us millions of partners 💥 🥊
100 000 actionnaires pour la planète, c’est possible et c’est maintenant avant le 31/12 minuit! 🌍👇Des entreprises doublent les investissements des nouveaux et investissent 1€ par like/comment/partage. Go !
👉 https://t.co/LiIHqbsaLf
#timefortheplanet
Thankful for the opportunity to attend The Longevity Summit organized by Longevity SF at the Buck Institute for Research on Aging in California earlier this month. Many great speakers and experts in the longevity field regrouped in a great venue!
Last bu…https://t.co/trer5ojITD
Excited to be part of this vibrant FASEB meeting on transcription, chromatin and epigenetics in aging in Sicily #TCESRC22! Looking forward to present the work we have accomplished at @DorianThera on Thursday 09/15. Thanks @Brunetlab and @giacomo_cavalli for the organization!
If you or anyone you know is taking rapamycin (sirolimus), please encourage them to participate in our survey-based study: https://t.co/uWFy8QIAuA
Real world data from people taking rapamycin off label is critically important for understanding safety and potential efficacy.
Big thank you to all mentors and lab members, past and present, for their support in getting our lab to this point. Grateful for the late Bill Bowes for his support of basic science @UCSF and the committee for selecting our group. Excited about the future!
https://t.co/hCwwESyAQK
Patient-Led Research Collaborative is accepting individual and organizational sign ons in the form below. You do not need to be a Long Covid organization to be an ally. Please join us in this fight!